English

BIO REFERENCE LABORATORIES INC

EDGAR

Quarterly report (10-Q) · filed 2015-06-09

85 filing records in this dataset, filed from 1995-06-08 to 2015-06-09. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

148 million USD

2011-07-31 · USD

Exact inputs and evidence

Revenue: 148029000 USD Source

Operating margin

12.44%

2011-07-31 · %

Exact inputs and evidence

Operating Income: 18409000 USD Source
Revenue: 148029000 USD Source

Cash and cash equivalents: 19.2 million USD 2011-07-31 Source
Exact value

19154000 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

534 million USD

2010-08-01 – 2011-07-31

Exact inputs and evidence

Revenue: 458024000 USD · 2009-11-01 – 2010-10-31 Source
Revenue: 331428000 USD · 2009-11-01 – 2010-07-31 Source
Revenue: 121659000 USD · 2010-11-01 – 2011-01-31 Source
Revenue: 137658000 USD · 2011-02-01 – 2011-04-30 Source
Revenue: 148029000 USD · 2011-05-01 – 2011-07-31 Source

Net income

34.5 million USD

2010-08-01 – 2011-07-31

Exact inputs and evidence

Net income: 26381000 USD · 2009-11-01 – 2010-10-31 Source
Net income: 17804000 USD · 2009-11-01 – 2010-07-31 Source
Net income: 7986000 USD · 2010-11-01 – 2011-01-31 Source
Net income: 7817000 USD · 2011-02-01 – 2011-04-30 Source
Net income: 10081000 USD · 2011-05-01 – 2011-07-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2015-06-09.

Financial data available through: 2010-10-31.

Financial coverage is incomplete. Newer filings are recorded, but comparable financial figures for those periods are not available here yet.

Coverage by financial measure

Revenue: 11 of 11 periods available· newest 2010-10-31
Operating income: 11 of 11 periods available· newest 2010-10-31
Net income: 11 of 11 periods available· newest 2010-10-31
operating cash flow: No compatible figures in this window
Capital expenditure: 8 of 11 periods available· newest 2007-10-31
Total assets: 11 of 11 periods available· newest 2010-10-31
liabilities: No compatible figures in this window
Current assets: 11 of 11 periods available· newest 2010-10-31
Current liabilities: 11 of 11 periods available· newest 2010-10-31
Cash and cash equivalents: 11 of 11 periods available· newest 2010-10-31
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+26.3%

Prior period

USD 362.65 million

2008-11-01 – 2009-10-31
Current period

USD 458.02 million

2009-11-01 – 2010-10-31

Exact inputs and evidence

458024000 − 362654000 = 95370000 USD

362654000 USD · 2008-11-01 – 2009-10-31
Inspect prior input Prior source
458024000 USD · 2009-11-01 – 2010-10-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · BIO REFERENCE LABORATORIES INC · 2010-10-31 BIO REFERENCE LABORATORIES INC (edgar:792641) Year-over-year change in Revenue: 95370000 USD Concept: fundies:Revenue Period: 2009-11-01 to 2010-10-31 Values: Latest reported Published: 2026-11-02T20:22:10Z Snapshot: 9e8c3e929bc2f4775b3937e53b6f5238038490103f4b2a3979a94264971a18a9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/792641?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 458024000 USD (2009-11-01 to 2010-10-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/792641/0001104659-11-001532.txt#8364 Input fundies:Revenue: 362654000 USD (2008-11-01 to 2009-10-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/792641/0001104659-11-001532.txt#8364
The citation records this snapshot. The page link may show a newer release later.
Net income
+20.7%

Prior period

USD 21.85 million

2008-11-01 – 2009-10-31
Current period

USD 26.38 million

2009-11-01 – 2010-10-31

Exact inputs and evidence

26381000 − 21850000 = 4531000 USD

21850000 USD · 2008-11-01 – 2009-10-31
Inspect prior input Prior source
26381000 USD · 2009-11-01 – 2010-10-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · BIO REFERENCE LABORATORIES INC · 2010-10-31 BIO REFERENCE LABORATORIES INC (edgar:792641) Year-over-year change in Net income: 4531000 USD Concept: fundies:NetIncome Period: 2009-11-01 to 2010-10-31 Values: Latest reported Published: 2026-11-02T20:22:10Z Snapshot: 9e8c3e929bc2f4775b3937e53b6f5238038490103f4b2a3979a94264971a18a9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/792641?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: 26381000 USD (2009-11-01 to 2010-10-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/792641/0001104659-11-001532.txt#10286 Input fundies:NetIncome: 21850000 USD (2008-11-01 to 2009-10-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/792641/0001104659-11-001532.txt#10286
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Operating cash flow, Capital expenditure.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2010 2009-11-01 – 2010-10-31

Revenue USD 458.02 million 100% of revenue
Operating costs Derived USD 409.65 million 89% of revenue
Operating income USD 48.38 million 11% of revenue
Tax, interest and other Derived USD 22 million 4.8% of revenue
Net income USD 26.38 million 5.8% of revenue

Cash

Operating cash flow Unavailable An input is unavailable.
Capital expenditure Unavailable An input is unavailable.
Free cash flow Derived Unavailable An input is unavailable.

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2001 96%
2002 94%
2003 91%
2004 91%
2005 92%
2006 91%
2007 90%
2008 91%
2009 89%
2010 89%

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2001 2000-11-01 – 2001-10-31	80622000	77015000 Derived	3607000	1246000 Derived	2361000	Unavailable	Source 2000-11-01 – 2001-10-31: 80622000 USD Inspect Revenue Open source 2000-11-01 – 2001-10-31: 3607000 USD Inspect Operating Income Open source 2000-11-01 – 2001-10-31: 2361000 USD Inspect Net Income Open source 2000-11-01 – 2001-10-31: 471000 USD Inspect Capital Expenditure Open source
2002 2001-11-01 – 2002-10-31	96631000	90559000 Derived	6072000	1150000 Derived	4922000	Unavailable	Source 2001-11-01 – 2002-10-31: 96631000 USD Inspect Revenue Open source 2001-11-01 – 2002-10-31: 6072000 USD Inspect Operating Income Open source 2001-11-01 – 2002-10-31: 4922000 USD Inspect Net Income Open source 2001-11-01 – 2002-10-31: 433000 USD Inspect Capital Expenditure Open source
2003 2002-11-01 – 2003-10-31	109034000	99749000 Derived	9285000	2745000 Derived	6540000	Unavailable	Source 2002-11-01 – 2003-10-31: 109034000 USD Inspect Revenue Open source 2002-11-01 – 2003-10-31: 9285000 USD Inspect Operating Income Open source 2002-11-01 – 2003-10-31: 6540000 USD Inspect Net Income Open source 2002-11-01 – 2003-10-31: 1105000 USD Inspect Capital Expenditure Open source
2004 2003-11-01 – 2004-10-31	136184000	123364000 Derived	12820000	4304000 Derived	8516000	Unavailable	Source 2003-11-01 – 2004-10-31: 136184000 USD Inspect Revenue Open source 2003-11-01 – 2004-10-31: 12820000 USD Inspect Operating Income Open source 2003-11-01 – 2004-10-31: 8516000 USD Inspect Net Income Open source 2003-11-01 – 2004-10-31: 3541000 USD Inspect Capital Expenditure Open source
2005 2004-11-01 – 2005-10-31	163896000	151289000 Derived	12607000	4986000 Derived	7621000	Unavailable	Source 2004-11-01 – 2005-10-31: 163896000 USD Inspect Revenue Open source 2004-11-01 – 2005-10-31: 12607000 USD Inspect Operating Income Open source 2004-11-01 – 2005-10-31: 7621000 USD Inspect Net Income Open source 2004-11-01 – 2005-10-31: 2860000 USD Inspect Capital Expenditure Open source
2006 2005-11-01 – 2006-10-31	193134000	175153000 Derived	17981000	6690000 Derived	11291000	Unavailable	Source 2005-11-01 – 2006-10-31: 193134000 USD Inspect Revenue Open source 2005-11-01 – 2006-10-31: 17981000 USD Inspect Operating Income Open source 2005-11-01 – 2006-10-31: 11291000 USD Inspect Net Income Open source 2005-11-01 – 2006-10-31: 2859000 USD Inspect Capital Expenditure Open source
2007 2006-11-01 – 2007-10-31	250431000	225374000 Derived	25057000	11100000 Derived	13957000	Unavailable	Source 2006-11-01 – 2007-10-31: 250431000 USD Inspect Revenue Open source 2006-11-01 – 2007-10-31: 25057000 USD Inspect Operating Income Open source 2006-11-01 – 2007-10-31: 13957000 USD Inspect Net Income Open source 2006-11-01 – 2007-10-31: 7745000 USD Inspect Capital Expenditure Open source
2008 2007-11-01 – 2008-10-31	301071000	272514000 Derived	28557000	12940000 Derived	15617000	Unavailable	Source 2007-11-01 – 2008-10-31: 301071000 USD Inspect Revenue Open source 2007-11-01 – 2008-10-31: 28557000 USD Inspect Operating Income Open source 2007-11-01 – 2008-10-31: 15617000 USD Inspect Net Income Open source
2009 2008-11-01 – 2009-10-31	362654000	324332000 Derived	38322000	16472000 Derived	21850000	Unavailable	Source 2008-11-01 – 2009-10-31: 362654000 USD Inspect Revenue Open source 2008-11-01 – 2009-10-31: 38322000 USD Inspect Operating Income Open source 2008-11-01 – 2009-10-31: 21850000 USD Inspect Net Income Open source
2010 2009-11-01 – 2010-10-31	458024000	409646000 Derived	48378000	21997000 Derived	26381000	Unavailable	Source 2009-11-01 – 2010-10-31: 458024000 USD Inspect Revenue Open source 2009-11-01 – 2010-10-31: 48378000 USD Inspect Operating Income Open source 2009-11-01 – 2010-10-31: 26381000 USD Inspect Net Income Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 458M 2010

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20012001-10-31	Revenue	80622000	Revenue: 80622000 Open source
20022002-10-31	Revenue	96631000	Revenue: 96631000 Open source
20032003-10-31	Revenue	109034000	Revenue: 109034000 Open source
20042004-10-31	Revenue	136184000	Revenue: 136184000 Open source
20052005-10-31	Revenue	163896000	Revenue: 163896000 Open source
20062006-10-31	Revenue	193134000	Revenue: 193134000 Open source
20072007-10-31	Revenue	250431000	Revenue: 250431000 Open source
20082008-10-31	Revenue	301071000	Revenue: 301071000 Open source
20092009-10-31	Revenue	362654000	Revenue: 362654000 Open source
20102010-10-31	Revenue	458024000	Revenue: 458024000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

26.3% 2010

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20012001-10-31	Year over year	21.3%	Revenue: 80622000 Open source Revenue: 66460073 Open source
20022002-10-31	Year over year	19.9%	Revenue: 96631000 Open source Revenue: 80622000 Open source
20032003-10-31	Year over year	12.8%	Revenue: 109034000 Open source Revenue: 96631000 Open source
20042004-10-31	Year over year	24.9%	Revenue: 136184000 Open source Revenue: 109034000 Open source
20052005-10-31	Year over year	20.3%	Revenue: 163896000 Open source Revenue: 136184000 Open source
20062006-10-31	Year over year	17.8%	Revenue: 193134000 Open source Revenue: 163896000 Open source
20072007-10-31	Year over year	29.7%	Revenue: 250431000 Open source Revenue: 193134000 Open source
20082008-10-31	Year over year	20.2%	Revenue: 301071000 Open source Revenue: 250431000 Open source
20092009-10-31	Year over year	20.5%	Revenue: 362654000 Open source Revenue: 301071000 Open source
20102010-10-31	Year over year	26.3%	Revenue: 458024000 Open source Revenue: 362654000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin 10.6% 2010

Net margin 5.8% 2010

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20012001-10-31	Operating margin	4.5%	Operating Income: 3607000 Open source Revenue: 80622000 Open source
20022002-10-31	Operating margin	6.3%	Operating Income: 6072000 Open source Revenue: 96631000 Open source
20032003-10-31	Operating margin	8.5%	Operating Income: 9285000 Open source Revenue: 109034000 Open source
20042004-10-31	Operating margin	9.4%	Operating Income: 12820000 Open source Revenue: 136184000 Open source
20052005-10-31	Operating margin	7.7%	Operating Income: 12607000 Open source Revenue: 163896000 Open source
20062006-10-31	Operating margin	9.3%	Operating Income: 17981000 Open source Revenue: 193134000 Open source
20072007-10-31	Operating margin	10%	Operating Income: 25057000 Open source Revenue: 250431000 Open source
20082008-10-31	Operating margin	9.5%	Operating Income: 28557000 Open source Revenue: 301071000 Open source
20092009-10-31	Operating margin	10.6%	Operating Income: 38322000 Open source Revenue: 362654000 Open source
20102010-10-31	Operating margin	10.6%	Operating Income: 48378000 Open source Revenue: 458024000 Open source
20012001-10-31	Net margin	2.9%	Net Income: 2361000 Open source Revenue: 80622000 Open source
20022002-10-31	Net margin	5.1%	Net Income: 4922000 Open source Revenue: 96631000 Open source
20032003-10-31	Net margin	6%	Net Income: 6540000 Open source Revenue: 109034000 Open source
20042004-10-31	Net margin	6.3%	Net Income: 8516000 Open source Revenue: 136184000 Open source
20052005-10-31	Net margin	4.6%	Net Income: 7621000 Open source Revenue: 163896000 Open source
20062006-10-31	Net margin	5.8%	Net Income: 11291000 Open source Revenue: 193134000 Open source
20072007-10-31	Net margin	5.6%	Net Income: 13957000 Open source Revenue: 250431000 Open source
20082008-10-31	Net margin	5.2%	Net Income: 15617000 Open source Revenue: 301071000 Open source
20092009-10-31	Net margin	6%	Net Income: 21850000 Open source Revenue: 362654000 Open source
20102010-10-31	Net margin	5.8%	Net Income: 26381000 Open source Revenue: 458024000 Open source
20012001-10-31	Free cash flow margin	Not reported	Revenue: 80622000 Open source Capital Expenditure: 471000 Open source
20022002-10-31	Free cash flow margin	Not reported	Revenue: 96631000 Open source Capital Expenditure: 433000 Open source
20032003-10-31	Free cash flow margin	Not reported	Revenue: 109034000 Open source Capital Expenditure: 1105000 Open source
20042004-10-31	Free cash flow margin	Not reported	Revenue: 136184000 Open source Capital Expenditure: 3541000 Open source
20052005-10-31	Free cash flow margin	Not reported	Revenue: 163896000 Open source Capital Expenditure: 2860000 Open source
20062006-10-31	Free cash flow margin	Not reported	Revenue: 193134000 Open source Capital Expenditure: 2859000 Open source
20072007-10-31	Free cash flow margin	Not reported	Revenue: 250431000 Open source Capital Expenditure: 7745000 Open source
20082008-10-31	Free cash flow margin	Not reported	Revenue: 301071000 Open source
20092009-10-31	Free cash flow margin	Not reported	Revenue: 362654000 Open source
20102010-10-31	Free cash flow margin	Not reported	Revenue: 458024000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

Not enough comparable data to show this history.

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20012001-10-31	Operating cash flow	Not reported	No source recorded
20022002-10-31	Operating cash flow	Not reported	No source recorded
20032003-10-31	Operating cash flow	Not reported	No source recorded
20042004-10-31	Operating cash flow	Not reported	No source recorded
20052005-10-31	Operating cash flow	Not reported	No source recorded
20062006-10-31	Operating cash flow	Not reported	No source recorded
20072007-10-31	Operating cash flow	Not reported	No source recorded
20082008-10-31	Operating cash flow	Not reported	No source recorded
20092009-10-31	Operating cash flow	Not reported	No source recorded
20102010-10-31	Operating cash flow	Not reported	No source recorded

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Not enough comparable data to show this history.

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20012001-10-31	Free cash flow	Unavailable	Capital Expenditure: 471000 Open source
20022002-10-31	Free cash flow	Unavailable	Capital Expenditure: 433000 Open source
20032003-10-31	Free cash flow	Unavailable	Capital Expenditure: 1105000 Open source
20042004-10-31	Free cash flow	Unavailable	Capital Expenditure: 3541000 Open source
20052005-10-31	Free cash flow	Unavailable	Capital Expenditure: 2860000 Open source
20062006-10-31	Free cash flow	Unavailable	Capital Expenditure: 2859000 Open source
20072007-10-31	Free cash flow	Unavailable	Capital Expenditure: 7745000 Open source
20082008-10-31	Free cash flow	Unavailable	No source recorded
20092009-10-31	Free cash flow	Unavailable	No source recorded
20102010-10-31	Free cash flow	Unavailable	No source recorded

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
2001-10-31	Liabilities / assets	Not reported	Total Assets: 44005737 Open source
2002-10-31	Liabilities / assets	Not reported	Total Assets: 47442000 Open source
2003-10-31	Liabilities / assets	Not reported	Total Assets: 53219000 Open source
2004-10-31	Liabilities / assets	Not reported	Total Assets: 72151000 Open source
2005-10-31	Liabilities / assets	Not reported	Total Assets: 88373000 Open source
2006-10-31	Liabilities / assets	Not reported	Total Assets: 120473000 Open source
2007-10-31	Liabilities / assets	Not reported	Total Assets: 154574000 Open source
2008-10-31	Liabilities / assets	Not reported	Total Assets: 171311000 Open source
2009-10-31	Liabilities / assets	Not reported	Total Assets: 197390000 Open source
2010-10-31	Liabilities / assets	Not reported	Total Assets: 244131000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

2.07× 2010

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20012001-10-31	Current assets / current liabilities	1.3×	Current Assets: 31631765 Open source Current Liabilities: 24374596 Open source
20022002-10-31	Current assets / current liabilities	1.58×	Current Assets: 34367000 Open source Current Liabilities: 21716000 Open source
20032003-10-31	Current assets / current liabilities	1.9×	Current Assets: 38730000 Open source Current Liabilities: 20428000 Open source
20042004-10-31	Current assets / current liabilities	1.88×	Current Assets: 50773000 Open source Current Liabilities: 26958000 Open source
20052005-10-31	Current assets / current liabilities	1.93×	Current Assets: 63239000 Open source Current Liabilities: 32724000 Open source
20062006-10-31	Current assets / current liabilities	1.89×	Current Assets: 84075000 Open source Current Liabilities: 44582000 Open source
20072007-10-31	Current assets / current liabilities	1.82×	Current Assets: 108497000 Open source Current Liabilities: 59750000 Open source
20082008-10-31	Current assets / current liabilities	1.96×	Current Assets: 119551000 Open source Current Liabilities: 60990000 Open source
20092009-10-31	Current assets / current liabilities	2.18×	Current Assets: 140473000 Open source Current Liabilities: 64489000 Open source
20102010-10-31	Current assets / current liabilities	2.07×	Current Assets: 172797000 Open source Current Liabilities: 83338000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2001 2000-11-01 – 2001-10-31	USD 2.36 million Exact value Exact value: 2361000 USD 2000-11-01 – 2001-10-31: 2361000 USD Inspect Net Income Open source Share or cite Citation for Net Income · BIO REFERENCE LABORATORIES INC · 2001-10-31 BIO REFERENCE LABORATORIES INC (edgar:792641) Net Income: 2361000 USD Concept: fundies:NetIncome Period: 2000-11-01 to 2001-10-31 Values: Latest reported Published: 2026-11-02T20:22:10Z Snapshot: 9e8c3e929bc2f4775b3937e53b6f5238038490103f4b2a3979a94264971a18a9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/792641/explain?concept=fundies%3ANetIncome&period=2001-10-31&surface=latest&period_type=duration&start=2000-11-01&unit=USD&dimensions= Input fundies:NetIncome: 2361000 USD (2000-11-01 to 2001-10-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/792641/0001104659-04-002061.txt#13155 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	USD 471,000 Exact value Exact value: 471000 USD 2000-11-01 – 2001-10-31: 471000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · BIO REFERENCE LABORATORIES INC · 2001-10-31 BIO REFERENCE LABORATORIES INC (edgar:792641) Capital Expenditure: 471000 USD Concept: fundies:CapitalExpenditure Period: 2000-11-01 to 2001-10-31 Values: Latest reported Published: 2026-11-02T20:22:10Z Snapshot: 9e8c3e929bc2f4775b3937e53b6f5238038490103f4b2a3979a94264971a18a9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/792641/explain?concept=fundies%3ACapitalExpenditure&period=2001-10-31&surface=latest&period_type=duration&start=2000-11-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 471000 USD (2000-11-01 to 2001-10-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/792641/0001104659-04-002061.txt#13818 The citation records this snapshot. The page link may show a newer release later.	Unavailable Free cash flow cannot be calculated because Operating cash flow is unavailable for this period.
2002 2001-11-01 – 2002-10-31	USD 4.92 million Exact value Exact value: 4922000 USD 2001-11-01 – 2002-10-31: 4922000 USD Inspect Net Income Open source Share or cite Citation for Net Income · BIO REFERENCE LABORATORIES INC · 2002-10-31 BIO REFERENCE LABORATORIES INC (edgar:792641) Net Income: 4922000 USD Concept: fundies:NetIncome Period: 2001-11-01 to 2002-10-31 Values: Latest reported Published: 2026-11-02T20:22:10Z Snapshot: 9e8c3e929bc2f4775b3937e53b6f5238038490103f4b2a3979a94264971a18a9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/792641/explain?concept=fundies%3ANetIncome&period=2002-10-31&surface=latest&period_type=duration&start=2001-11-01&unit=USD&dimensions= Input fundies:NetIncome: 4922000 USD (2001-11-01 to 2002-10-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/792641/0001104659-05-001448.txt#15089 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	USD 433,000 Exact value Exact value: 433000 USD 2001-11-01 – 2002-10-31: 433000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · BIO REFERENCE LABORATORIES INC · 2002-10-31 BIO REFERENCE LABORATORIES INC (edgar:792641) Capital Expenditure: 433000 USD Concept: fundies:CapitalExpenditure Period: 2001-11-01 to 2002-10-31 Values: Latest reported Published: 2026-11-02T20:22:10Z Snapshot: 9e8c3e929bc2f4775b3937e53b6f5238038490103f4b2a3979a94264971a18a9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/792641/explain?concept=fundies%3ACapitalExpenditure&period=2002-10-31&surface=latest&period_type=duration&start=2001-11-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 433000 USD (2001-11-01 to 2002-10-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/792641/0001104659-05-001448.txt#15776 The citation records this snapshot. The page link may show a newer release later.	Unavailable Free cash flow cannot be calculated because Operating cash flow is unavailable for this period.
2003 2002-11-01 – 2003-10-31	USD 6.54 million Exact value Exact value: 6540000 USD 2002-11-01 – 2003-10-31: 6540000 USD Inspect Net Income Open source Share or cite Citation for Net Income · BIO REFERENCE LABORATORIES INC · 2003-10-31 BIO REFERENCE LABORATORIES INC (edgar:792641) Net Income: 6540000 USD Concept: fundies:NetIncome Period: 2002-11-01 to 2003-10-31 Values: Latest reported Published: 2026-11-02T20:22:10Z Snapshot: 9e8c3e929bc2f4775b3937e53b6f5238038490103f4b2a3979a94264971a18a9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/792641/explain?concept=fundies%3ANetIncome&period=2003-10-31&surface=latest&period_type=duration&start=2002-11-01&unit=USD&dimensions= Input fundies:NetIncome: 6540000 USD (2002-11-01 to 2003-10-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/792641/0001104659-06-002298.txt#16303 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	USD 1.11 million Exact value Exact value: 1105000 USD 2002-11-01 – 2003-10-31: 1105000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · BIO REFERENCE LABORATORIES INC · 2003-10-31 BIO REFERENCE LABORATORIES INC (edgar:792641) Capital Expenditure: 1105000 USD Concept: fundies:CapitalExpenditure Period: 2002-11-01 to 2003-10-31 Values: Latest reported Published: 2026-11-02T20:22:10Z Snapshot: 9e8c3e929bc2f4775b3937e53b6f5238038490103f4b2a3979a94264971a18a9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/792641/explain?concept=fundies%3ACapitalExpenditure&period=2003-10-31&surface=latest&period_type=duration&start=2002-11-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1105000 USD (2002-11-01 to 2003-10-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/792641/0001104659-06-002298.txt#17016 The citation records this snapshot. The page link may show a newer release later.	Unavailable Free cash flow cannot be calculated because Operating cash flow is unavailable for this period.
2004 2003-11-01 – 2004-10-31	USD 8.52 million Exact value Exact value: 8516000 USD 2003-11-01 – 2004-10-31: 8516000 USD Inspect Net Income Open source Share or cite Citation for Net Income · BIO REFERENCE LABORATORIES INC · 2004-10-31 BIO REFERENCE LABORATORIES INC (edgar:792641) Net Income: 8516000 USD Concept: fundies:NetIncome Period: 2003-11-01 to 2004-10-31 Values: Latest reported Published: 2026-11-02T20:22:10Z Snapshot: 9e8c3e929bc2f4775b3937e53b6f5238038490103f4b2a3979a94264971a18a9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/792641/explain?concept=fundies%3ANetIncome&period=2004-10-31&surface=latest&period_type=duration&start=2003-11-01&unit=USD&dimensions= Input fundies:NetIncome: 8516000 USD (2003-11-01 to 2004-10-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/792641/0001104659-07-002308.txt#16049 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	USD 3.54 million Exact value Exact value: 3541000 USD 2003-11-01 – 2004-10-31: 3541000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · BIO REFERENCE LABORATORIES INC · 2004-10-31 BIO REFERENCE LABORATORIES INC (edgar:792641) Capital Expenditure: 3541000 USD Concept: fundies:CapitalExpenditure Period: 2003-11-01 to 2004-10-31 Values: Latest reported Published: 2026-11-02T20:22:10Z Snapshot: 9e8c3e929bc2f4775b3937e53b6f5238038490103f4b2a3979a94264971a18a9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/792641/explain?concept=fundies%3ACapitalExpenditure&period=2004-10-31&surface=latest&period_type=duration&start=2003-11-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 3541000 USD (2003-11-01 to 2004-10-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/792641/0001104659-07-002308.txt#16763 The citation records this snapshot. The page link may show a newer release later.	Unavailable Free cash flow cannot be calculated because Operating cash flow is unavailable for this period.
2005 2004-11-01 – 2005-10-31	USD 7.62 million Exact value Exact value: 7621000 USD 2004-11-01 – 2005-10-31: 7621000 USD Inspect Net Income Open source Share or cite Citation for Net Income · BIO REFERENCE LABORATORIES INC · 2005-10-31 BIO REFERENCE LABORATORIES INC (edgar:792641) Net Income: 7621000 USD Concept: fundies:NetIncome Period: 2004-11-01 to 2005-10-31 Values: Latest reported Published: 2026-11-02T20:22:10Z Snapshot: 9e8c3e929bc2f4775b3937e53b6f5238038490103f4b2a3979a94264971a18a9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/792641/explain?concept=fundies%3ANetIncome&period=2005-10-31&surface=latest&period_type=duration&start=2004-11-01&unit=USD&dimensions= Input fundies:NetIncome: 7621000 USD (2004-11-01 to 2005-10-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/792641/0001104659-08-002538.txt#17230 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	USD 2.86 million Exact value Exact value: 2860000 USD 2004-11-01 – 2005-10-31: 2860000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · BIO REFERENCE LABORATORIES INC · 2005-10-31 BIO REFERENCE LABORATORIES INC (edgar:792641) Capital Expenditure: 2860000 USD Concept: fundies:CapitalExpenditure Period: 2004-11-01 to 2005-10-31 Values: Latest reported Published: 2026-11-02T20:22:10Z Snapshot: 9e8c3e929bc2f4775b3937e53b6f5238038490103f4b2a3979a94264971a18a9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/792641/explain?concept=fundies%3ACapitalExpenditure&period=2005-10-31&surface=latest&period_type=duration&start=2004-11-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2860000 USD (2004-11-01 to 2005-10-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/792641/0001104659-08-002538.txt#17864 The citation records this snapshot. The page link may show a newer release later.	Unavailable Free cash flow cannot be calculated because Operating cash flow is unavailable for this period.
2006 2005-11-01 – 2006-10-31	USD 11.29 million Exact value Exact value: 11291000 USD 2005-11-01 – 2006-10-31: 11291000 USD Inspect Net Income Open source Share or cite Citation for Net Income · BIO REFERENCE LABORATORIES INC · 2006-10-31 BIO REFERENCE LABORATORIES INC (edgar:792641) Net Income: 11291000 USD Concept: fundies:NetIncome Period: 2005-11-01 to 2006-10-31 Values: Latest reported Published: 2026-11-02T20:22:10Z Snapshot: 9e8c3e929bc2f4775b3937e53b6f5238038490103f4b2a3979a94264971a18a9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/792641/explain?concept=fundies%3ANetIncome&period=2006-10-31&surface=latest&period_type=duration&start=2005-11-01&unit=USD&dimensions= Input fundies:NetIncome: 11291000 USD (2005-11-01 to 2006-10-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/792641/0001104659-09-002204.txt#18038 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	USD 2.86 million Exact value Exact value: 2859000 USD 2005-11-01 – 2006-10-31: 2859000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · BIO REFERENCE LABORATORIES INC · 2006-10-31 BIO REFERENCE LABORATORIES INC (edgar:792641) Capital Expenditure: 2859000 USD Concept: fundies:CapitalExpenditure Period: 2005-11-01 to 2006-10-31 Values: Latest reported Published: 2026-11-02T20:22:10Z Snapshot: 9e8c3e929bc2f4775b3937e53b6f5238038490103f4b2a3979a94264971a18a9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/792641/explain?concept=fundies%3ACapitalExpenditure&period=2006-10-31&surface=latest&period_type=duration&start=2005-11-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2859000 USD (2005-11-01 to 2006-10-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/792641/0001104659-08-002538.txt#17864 The citation records this snapshot. The page link may show a newer release later.	Unavailable Free cash flow cannot be calculated because Operating cash flow is unavailable for this period.
2007 2006-11-01 – 2007-10-31	USD 13.96 million Exact value Exact value: 13957000 USD 2006-11-01 – 2007-10-31: 13957000 USD Inspect Net Income Open source Share or cite Citation for Net Income · BIO REFERENCE LABORATORIES INC · 2007-10-31 BIO REFERENCE LABORATORIES INC (edgar:792641) Net Income: 13957000 USD Concept: fundies:NetIncome Period: 2006-11-01 to 2007-10-31 Values: Latest reported Published: 2026-11-02T20:22:10Z Snapshot: 9e8c3e929bc2f4775b3937e53b6f5238038490103f4b2a3979a94264971a18a9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/792641/explain?concept=fundies%3ANetIncome&period=2007-10-31&surface=latest&period_type=duration&start=2006-11-01&unit=USD&dimensions= Input fundies:NetIncome: 13957000 USD (2006-11-01 to 2007-10-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/792641/0001104659-10-001349.txt#18196 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	USD 7.75 million Exact value Exact value: 7745000 USD 2006-11-01 – 2007-10-31: 7745000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · BIO REFERENCE LABORATORIES INC · 2007-10-31 BIO REFERENCE LABORATORIES INC (edgar:792641) Capital Expenditure: 7745000 USD Concept: fundies:CapitalExpenditure Period: 2006-11-01 to 2007-10-31 Values: Latest reported Published: 2026-11-02T20:22:10Z Snapshot: 9e8c3e929bc2f4775b3937e53b6f5238038490103f4b2a3979a94264971a18a9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/792641/explain?concept=fundies%3ACapitalExpenditure&period=2007-10-31&surface=latest&period_type=duration&start=2006-11-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 7745000 USD (2006-11-01 to 2007-10-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/792641/0001104659-08-002538.txt#17864 The citation records this snapshot. The page link may show a newer release later.	Unavailable Free cash flow cannot be calculated because Operating cash flow is unavailable for this period.
2008 2007-11-01 – 2008-10-31	USD 15.62 million Exact value Exact value: 15617000 USD 2007-11-01 – 2008-10-31: 15617000 USD Inspect Net Income Open source Share or cite Citation for Net Income · BIO REFERENCE LABORATORIES INC · 2008-10-31 BIO REFERENCE LABORATORIES INC (edgar:792641) Net Income: 15617000 USD Concept: fundies:NetIncome Period: 2007-11-01 to 2008-10-31 Values: Latest reported Published: 2026-11-02T20:22:10Z Snapshot: 9e8c3e929bc2f4775b3937e53b6f5238038490103f4b2a3979a94264971a18a9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/792641/explain?concept=fundies%3ANetIncome&period=2008-10-31&surface=latest&period_type=duration&start=2007-11-01&unit=USD&dimensions= Input fundies:NetIncome: 15617000 USD (2007-11-01 to 2008-10-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/792641/0001104659-11-001532.txt#10286 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.
2009 2008-11-01 – 2009-10-31	USD 21.85 million Exact value Exact value: 21850000 USD 2008-11-01 – 2009-10-31: 21850000 USD Inspect Net Income Open source Share or cite Citation for Net Income · BIO REFERENCE LABORATORIES INC · 2009-10-31 BIO REFERENCE LABORATORIES INC (edgar:792641) Net Income: 21850000 USD Concept: fundies:NetIncome Period: 2008-11-01 to 2009-10-31 Values: Latest reported Published: 2026-11-02T20:22:10Z Snapshot: 9e8c3e929bc2f4775b3937e53b6f5238038490103f4b2a3979a94264971a18a9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/792641/explain?concept=fundies%3ANetIncome&period=2009-10-31&surface=latest&period_type=duration&start=2008-11-01&unit=USD&dimensions= Input fundies:NetIncome: 21850000 USD (2008-11-01 to 2009-10-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/792641/0001104659-11-001532.txt#10286 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.
2010 2009-11-01 – 2010-10-31	USD 26.38 million Exact value Exact value: 26381000 USD 2009-11-01 – 2010-10-31: 26381000 USD Inspect Net Income Open source Share or cite Citation for Net Income · BIO REFERENCE LABORATORIES INC · 2010-10-31 BIO REFERENCE LABORATORIES INC (edgar:792641) Net Income: 26381000 USD Concept: fundies:NetIncome Period: 2009-11-01 to 2010-10-31 Values: Latest reported Published: 2026-11-02T20:22:10Z Snapshot: 9e8c3e929bc2f4775b3937e53b6f5238038490103f4b2a3979a94264971a18a9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/792641/explain?concept=fundies%3ANetIncome&period=2010-10-31&surface=latest&period_type=duration&start=2009-11-01&unit=USD&dimensions= Input fundies:NetIncome: 26381000 USD (2009-11-01 to 2010-10-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/792641/0001104659-11-001532.txt#10286 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

85 filings · 0 latest values · 0 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0000792641, 792641, edgar:792641

BIO REFERENCE LABORATORIES INC

Latest quarter

Revenue

Operating margin

Trailing twelve months

Revenue

Net income

Company performance

What changed year over year

Revenue

Net income

Where revenue goes

2010 2009-11-01 – 2010-10-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation